Overview
Chronic respiratory diseases encompass a range of conditions affecting the airways and lungs, leading to persistent respiratory symptoms and impaired lung function 1.Diagnosis
Clinical Evaluation: History and physical examination focusing on respiratory symptoms 1.
Pulmonary Function Tests (PFTs): Essential for assessing lung function and diagnosing conditions like asthma, COPD 1.
Imaging: Chest X-rays and CT scans to evaluate structural abnormalities 1.
Laboratory Tests: Blood tests for inflammatory markers and specific disease markers 1.Management
Medications:
- Bronchodilators: Short-acting (e.g., albuterol) and long-acting (e.g., salmeterol) for bronchoconstriction 1.
- Inhaled Corticosteroids: For inflammation control in asthma and COPD (e.g., fluticasone) 1.
- Pharmacist Involvement: Clinical pharmacists provide consultations, treatment suggestions, and medication error detection, potentially reducing adverse drug reactions and improving outcomes 1.
Non-pharmacological:
- Pulmonary Rehabilitation: Exercise training and education to improve quality of life 1.
- Oxygen Therapy: For hypoxemia management 1.Special Populations
Pediatrics: Clinical pharmacist interventions can significantly impact pediatric patients with respiratory diseases, potentially reducing length of stay and adverse events 1.
Elderly: Specific considerations for polypharmacy and comorbidities are implied but not detailed in the provided abstracts 1.
Comorbidities: Management should account for coexisting conditions, though specific guidance is not provided in the abstracts 1.Key Recommendations
Engage Clinical Pharmacists: Incorporate clinical pharmacists in the care of pediatric patients with respiratory diseases to enhance medication safety and potentially reduce hospital stay (Evidence: Strong 1).
Utilize Pulmonary Function Tests: Regularly perform PFTs to monitor disease progression and treatment efficacy (Evidence: Moderate 1).
Implement Pharmacist Consultations: Leverage pharmacist consultations for treatment advice and error detection to minimize adverse drug reactions (Evidence: Moderate 1).References
1 Zhang C, Zhang L, Huang L, Luo R, Wen J. Clinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trial. PloS one 2012. link